Mongolia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID 19 in Adults in Mongolia- Mongolia, Indonesia, Australia Coronavirus (MIACoV).
Condition:   COVID-19 Interventions:   Biological: Tozinameran - Standard Dose;   Biological: Tozinameran - Fractional Dose Sponsors:   Murdoch Childrens Research Institute;   Coalition for Epidemic Preparedness Innovations;   PATH;   The Peter Doherty Institute for Infection and Immunity Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2022 Category: Research Source Type: clinical trials